Recently, the American Institute for Medical and Biological Engineering (AIMBE) announced the list of 153 newly elected fellows from around the world in 2022 in recognition of their outstanding achievements in medicine and bioengineering.

According to statistics from Leifeng.com, 39 Chinese scholars have been elected, accounting for 25%.

Fellowship of the American Academy of Medicine and Biological Engineering (AIMBE Fellow) is one of the highest professional honors in the field of medical and biological engineering.

Currently, AIMBE Fellow members include 3 Nobel Prize winners, 18 members who have received the Presidential Medal for Science, Technology and Innovation, 201 members of the National Academy of Engineering, 101 members of the National Academy of Sciences, and 45 members of the National Academy of Sciences.

The following is a list of scholars working in domestic institutions: Chen Xuesi Chen Xuesi, academician of the Chinese Academy of Sciences, executive deputy director and doctoral supervisor of the Academic Committee of Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, deputy director of the Academic Committee of the Key Laboratory of Ecological Environment Polymer Materials, Chinese Academy of Sciences,

Leader of the biopolymer research group.

After graduating from the Changchun Institute of Applied Chemistry, Chinese Academy of Sciences in 1988 with a master's degree, he stayed at the institute to work. He then received a doctorate from Waseda University and engaged in postdoctoral research at the University of Pennsylvania in the United States.

In 1999, Chen Xuesi returned to work at the Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, and served successively as a researcher and doctoral supervisor, engaged in biodegradable medical polymer materials, tissue engineering and drug sustained release, and the industrialization of polylactic acid and poly-caprolactone.

direction of research and development work.

In 2016, Chen Xuesi was elected as a fellow of the International Federation of Biomaterials and Engineering, and in 2019, he was elected as an academician of the Chinese Academy of Sciences.

As the project leader, Chen Xuesi once undertook the National Ministry of Science and Technology’s “13th Five-Year Plan” key R&D plan projects, the National Natural Science Foundation of China Basic Research Center project, etc.

In cooperation with Zhejiang Hisun Group, we have realized the industrialization of 15,000 tons of polylactic acid, and our technical level has reached an internationally leading level.

Reasons for selection: Contributions to the development of biodegradable polymers for gene and drug delivery, nanomedicine, tissue engineering, and large-scale production and commercialization.

Ma Guanghui Ma Guanghui, academician of the Chinese Academy of Sciences, researcher and doctoral supervisor at the Institute of Process Engineering, Chinese Academy of Sciences, director of the State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, director of the National Biochemical Engineering Technology Research Center (Beijing), and deputy director of the Chinese Particle Society

Chairman, Vice Chairman of the Biochemical Engineering Committee of the Chinese Chemical Society, and Director of the Chinese Bioengineering Society.

In 1984, Ma Guanghui studied abroad at Gunma University in Japan and obtained a bachelor's degree in fiber polymer engineering. In 1990 and 1993, he obtained a master's degree and a doctorate in polymer engineering from Tokyo Institute of Technology respectively.

After receiving his PhD, Ma Guanghui served as an assistant professor at the Graduate School of Applied Science of Biosystems, Tokyo University of Agriculture and Technology.

After returning to China in 2001, he was selected into the "Hundred Talents Program" of the Chinese Academy of Sciences and served as a researcher and doctoral supervisor at the Institute of Process Engineering, Chinese Academy of Sciences.

After returning to China, Ma Guanghui was mainly engaged in the preparation of uniform biological microspheres and microcapsules and their application in biochemical engineering and medical engineering. He also researched and developed protein/vaccine separation media, sustained and controlled release drug carriers, and immune adjuvants (vaccine delivery systems).

), cell culture microcarriers, enzyme immobilized carriers and other innovative products.

According to the Institute of Process Engineering of the Chinese Academy of Sciences, Ma Guanghui *** has obtained 88 Chinese invention patent authorizations and 12 international patent authorizations. Patented technologies and products have been applied by more than 500 units at home and abroad.

Reason for selection: Contributions to bioengineering through innovative membrane emulsification technology and particle system design for biomedical formulations.

Nie Guangjun Nie Guangjun, Distinguished Researcher of the Chinese Academy of Sciences, Distinguished Professor of the University of Science and Technology of China, Chief Scientist of the National Major Scientific Research Project on Nano Research of the Ministry of Science and Technology, Chief Scientist of the National Key Research and Development Program, Executive Director of the Chinese Biophysical Society, Member of the Nano-Oncology Professional Committee of the Chinese Anti-Cancer Association,

Member of the Nanomedicine Professional Committee of the Chinese Pharmaceutical Association.

In 2002, Nie Guangjun received his PhD from the Institute of Biophysics, Chinese Academy of Sciences, and then engaged in postdoctoral research at McGill University in Canada.